Dietary Fiber Supplementation ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04421313 (ClinicalTrials.gov) | September 2, 2020 | 18/5/2020 | Fibres Supplementation in Rheumatoid Arthritis | Supplementation of Rheumatoid Arthritis Patients With Dietary Fibre to Improve Their Gut Microbiota | Rheumatoid Arthritis | Drug: Dietary Fiber Supplementation | University Hospital, Montpellier | University of Sydney;Institut de Génétique Moléculaire de Montpellier | Recruiting | 18 Years | 85 Years | All | 87 | N/A | France |